The NIHR Invention for Innovation (i4i) programme invites proposals to Call 28 of its researcher-led Product Development Awards (PDA)
The i4i Product Development Awards (PDA) supports collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care systems. PDA are researcher-led and aim to de-risk innovations, supporting early product development and real-world evaluation, to make them more attractive for follow-on funding and further commercial investment. The expected focus of a PDA project is to:
- carry out product development required to enable technologies for clinical use or use in social care,
- carry out the clinical development of a laboratory-validated technology, and/or
- accelerate the development and uptake of innovative products, which already have demonstrated safety and efficacy.
The aim is to accelerate benefits to patients and end users, de-risk the technologies and make them attractive to follow-on funders, investors and buyers, in particular NHS commissioners and national guidance bodies. Projects must have demonstrated proof-of-concept as a minimum, which is generally described as TRL3.
Essential requirements for Product Development Awards
- Any R&D activities must be within the scope of our funding programme (more information can be found on the i4i webpage).
- A minimum of two organisations must be involved
- Lead applicants must be based in the UK
- Work packages must not include animal studies
- Projects must have progressed beyond basic research and have demonstrated proof-of-concept
The call opens on 10 April 2024 and the deadline for this call is on 29 May 2024 (13:00 BST).
Please complete and submit your application on the Research Management System (RMS). Please note that the RMS is the only mode of submission.
Opportunity provided by NIHR, learn more here.